Use of inhaled steroids increases risk of nontuberculous mycobacteria pulmonary infections
Use of inhaled corticosteroids, particularly use of high dose inhaled corticosteroids and long-term use was associated with 2.7 times increased risk of nontuberculous mycobacteria pulmonary infections, according to new research published online September 14, 2018 in the Annals of the American Thoracic Society.
Read the full story.
Create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies